Science and Technology Daily: Chorus of a Community of Shared Future for Mankind -- China Unite the World to Fight Against the Covid-19

Science and Technology Daily

PR83200

 

BEIJING, Mar. 6, 2020 /PRNewswire=KYODO JBN/--

 

Science and Technology Daily reported:

 

A timeline clearly recorded how China has taken the initiative to fulfill its

international responsibilities and unite with the global society to fight against

Covid-19. After the coronavirus outbroke, China immediately informed

the WHO of the incident and maintained close communication with other countries.

 

On January 12, the WHO acknowledged the information of Covid-19's gene

sequences shared by China.

 

On January 21, Chinese officials released the primers and probe sequences for

Covid-19's nucleic acid detection.

 

From February 16 to 24, a WHO-China investigation team composed of professionals

from different countries conducted a nine-day joint mission in China's four provinces.

Meanwhile, China also offered instant supports as far as it could to the countries and

regions that suffered from the spread of the Covid-19.

 

On February 24, Bruce Aylward, the leader of the investigation team, said in a

press conference: "To the people of Wuhan, it is recognized that the world is

in your debts." His words touched millions of people.

 

The sincere thanks from the international officials reflect a full recognition

of China's great sacrifice and contributions to the war against the spread of

Covid-19.

 

As reported by the investigation team, the decline of new cases of Covid-19 in

China undoubtedly protected world security. It built the first line of defense

to prevent the spread of Covid-19 throughout the world.

 

The team suggested that during the war against Covid-19, each country should

actively monitor health situations, take actions for detection, diagnosis,

isolation, and treatment as early as possible, and strictly track and isolate

individuals having close contacts with Covid-19 patients. This is a valuable

experience accumulated by China.

 

In addition, getting rid of prejudice and applying a variety of scientific and

flexible methods into this war is the second suggestion from the team.

For the novel virus like Covid-19, there is neither specific medicine nor vaccine.

However, only the reaction of China to Covid-19 has been proved successful by

facts, hence worth being learned by other countries.

 

In terms of scientific prevention and control of Covid-19, the action of

China's leaders shows the world that "Science and Technology" is the most

powerful weapon in the war against diseases. The laboratory of Tsinghua

University's Beijing National Engineering Research Center for Biochips

displayed the latest scientific achievements -- six microarray nucleic acid

testing kits for respiratory viruses, and eight microarray nucleic acid testing

kits for respiratory pathogens approved by China's National Medical Products

Administration. These two microfluidic chips can effectively shunt patients

through differential diagnosis. They have been put into clinical use in the

Union Hospital affiliated to Huazhong University of Science and Technology,

Tongji Hospital, Hubei Provincial People's Hospital, and "Huoshenshan" Hospital.

 

In the face of unknown viruses, human beings have not yet fully understood

their generation mechanism, epidemic trend, transmission route, etc., which

greatly requires information sharing and cooperation. China has developed

effective methods for diagnosis and treatment, drug efficacy, community

prevention, and public health education. It is being actively engaged in

cooperation and information exchange with the WHO and the international

community. The global efforts in the fight against epidemics create a chorus of

the community with a shared future for mankind.

 

SOURCE: Science and Technology Daily

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中